Senate LDA lobbying filing

ABBOTT LABORATORIES

Registrant: TIBER CREEK GROUP Year: 2026 Period: First Quarter Type: Q1

View on lda.senate.gov ↗

Reported income

$50.0K

Reported expenses

not reported

Tracked program mentions1

Quoted activity text is clipped to a short extract; each filing’s full description is under Lobbying activities below.

SPQ-9B Radar2026matched: “2026”PE code cited directly
Issues related to global health policy and funding; Issues related to the Consolidated Appropriations Act, 2026 (PL…

Lobbying activities2

Budget/AppropriationsBUD
Issues related to global health policy and funding; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75).
Foreign RelationsFOR
Issues related to global health policy and funding.

Lobbyists4

JENNIFER OLSON
JOHN TWOMEY
MATTHEW LEFFINGWELL
NIKOLE BURROUGHS

Source: U.S. Senate Lobbying Disclosure Act database. Dollar figures (underlined) cite the filing record on lda.senate.gov — click to view the citation. Amounts shown as “not reported” are absent from the filing itself.